Join a NASH Clinical Trial Near You

Adults diagnosed with NASH may be eligible to participate in ongoing studies evaluating new treatment options. During the trial, participants receive close medical supervision while researchers assess safety, effectiveness, and overall impact on liver health.

Questions or Interested in a Trial?

This field is for validation purposes and should be left unchanged.

Nonalcoholic Steatohepatitis Research Study Near You

Nonalcoholic steatohepatitis (NASH) is a progressive liver condition marked by fat buildup, inflammation, and potential liver damage. It often develops with minimal symptoms, making early management important.

Ongoing NASH clinical trials are focused on identifying more effective ways to manage the condition, prevent complications, and improve long-term health outcomes for those affected.

All data is securely managed using HIPAA-compliant systems, with strict privacy safeguards and controlled access.

Studies generally range from Phase II to Phase IV, focusing on evaluating safety, effectiveness, and how treatments perform over time.

You may be asked to attend a follow-up visit, and the study team will help ensure a smooth transition back to your regular care provider.

Participation offers structured medical oversight and the opportunity to access new therapies that are still under investigation.

No, participation is entirely voluntary. You are free to withdraw at any stage without any impact on your standard medical care.